- Home
- SST vs VANI Comparison
SST vs VANI Comparison
Compare SST & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- VANI
- Stock Information
- Founded
- SST 2013
- VANI 1998
- Country
- SST United States
- VANI United States
- Employees
- SST N/A
- VANI N/A
- Industry
- SST Diversified Commercial Services
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SST Consumer Discretionary
- VANI Health Care
- Exchange
- SST Nasdaq
- VANI Nasdaq
- Market Cap
- SST 67.8M
- VANI 69.9M
- IPO Year
- SST N/A
- VANI 2014
- Fundamental
- Price
- SST $0.61
- VANI $1.20
- Analyst Decision
- SST Hold
- VANI Strong Buy
- Analyst Count
- SST 1
- VANI 1
- Target Price
- SST $2.00
- VANI $3.00
- AVG Volume (30 Days)
- SST 168.5K
- VANI 134.7K
- Earning Date
- SST 03-17-2025
- VANI 11-13-2024
- Dividend Yield
- SST N/A
- VANI N/A
- EPS Growth
- SST N/A
- VANI N/A
- EPS
- SST N/A
- VANI N/A
- Revenue
- SST $364,450,000.00
- VANI N/A
- Revenue This Year
- SST N/A
- VANI N/A
- Revenue Next Year
- SST $2.59
- VANI N/A
- P/E Ratio
- SST N/A
- VANI N/A
- Revenue Growth
- SST N/A
- VANI N/A
- 52 Week Low
- SST $0.60
- VANI $1.01
- 52 Week High
- SST $2.73
- VANI $7.80
- Technical
- Relative Strength Index (RSI)
- SST 31.23
- VANI 43.85
- Support Level
- SST $0.60
- VANI $1.17
- Resistance Level
- SST $0.70
- VANI $1.23
- Average True Range (ATR)
- SST 0.09
- VANI 0.05
- MACD
- SST -0.02
- VANI 0.00
- Stochastic Oscillator
- SST 3.18
- VANI 31.58
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.